Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas

American Journal of Pathology

Volumn 148, Issue 3, 1996, Pages 763-775

  Hatva, Erika ^a   Böhling, Tom ^a   Jääskeläinen, Juha ^a   Persico, M Graziella ^b   Haltia, Matti ^a   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LECTIN RECEPTOR; LYMPHOKINE; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; PROTEIN TYROSINE KINASE; TIE RECEPTOR; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ARTICLE; CELL CULTURE; HEMANGIOBLASTOMA; HEMANGIOPERICYTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; NORTHERN BLOTTING; PATHOLOGY;

ANGIOGENESIS INDUCING AGENTS; BLOTTING, NORTHERN; ENDOTHELIAL GROWTH FACTORS; HEMANGIOBLASTOMA; HEMANGIOPERICYTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; PREGNANCY PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, MITOGEN; RECEPTORS, TIE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030091641     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267:10931-10934
2. Folkman J. What is the evidence that tumours are angiogenesis dependent? J Natl Cancer Inst 1990, 82 4-6
3. Weidner N, Semple P, Welch W, Folkman J: Tumour angiogenesis and metastases-correlation in invasive breast carcinoma N Engl J Med 1991, 324.1-8
4. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothehal cell adhesion molecule antibodies, as an indicator of node metastases and survival in breast cancer Lancet 1992, 340:1120-1124
5. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA Relation of neovascularisation to metastases of non-small-cell lung cancer Lancet 1992, 340 145-146
6. Srivastava A, Laidler P, Davies RP, Morgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4 O mm thick) skin melanoma. Am J Pathol 1988, 133:419-423
7. Kaipainen A, Vlaykova T, Hatva E, Böhling T, Jekunen A, Pyrhonen S, Alitalo K: Enhanced expression of the Tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas Cancer Res 1994, 54 6571-6577
8. Hatva E, Kaipainen K. Mentula P, Jääskeläinen J, Paetau A, Haltia M, Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995, 146 368-378
9. Chaudhry AP, Montes M, Cohn GA: Ultrastructure of cerebellar hemangioblastoma Cancer 1978, 42 1834-1850
10. Spence AM, Rubinstein LJ Cerebellar capillary hemangioblastoma: its histogenesis studied by organ culture and electron microscopy Cancer 1975, 35 326-341
11. Neumann H, Eggert H, Scheremet R, Schumacher M, Mohadjer M, Wakhloo AK, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 1992, 55:898-901
12. Stout AP, Murray MR Hemangiopencytoma: a vascular tumour featuring Zimmermann's pericytes. Ann Surg 1942, 116 26-33
13. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfindo JJ, Siegel RM, Leimgruber RM, Feder J: Tumour vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989, 84 1470-1478
14. Leung DW, Cachianes G, Kuang WJ, Goeddel D, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic milogen. Science 1989, 146:1306-1309
15. Ferrara N, Henzel WJ Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells Biochem Biophys Res Commun 1989, 161:851-858
16. Gospodarowicz D, Abraham JA, Schilling J: Isolation and characterization of a vascular endotheliai cell mitogen produced by pituitary-derived folliculo stellate cells Proc Natl Acad Sci USA 1989, 86.7311-7315
17. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989, 246.1309-1312
18. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA Purification of a glycoprotein vascular endothelial cell mitogen from a rat gliorna-derived cell line Proc Natl Acad Sci USA 1990, 87 1323-1327
19. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG Isolation of human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991, 88 9267-9271
20. Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Del Vecchio S, Lei KJ, Chou JY, Persico MG. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PLGF) are transcribed from a single gene of chromosome 14 Oncogene 1993, 8925-931
21. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ. Expression of vascular permeability factor (vascular endotheliai growth factor) and its receptors in breast cancer Hum Pathol 1995, 26.86-91
22. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, Twentyman PR, Smith SK. Expression of vascular endotheliai growth factor and its receptors fit and KDR in ovarian carcinoma. J Natl Cancer Inst 1995, 87:506-516
23. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993, 53:4727-4735
24. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993, 143 1255-1262
25. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845
26. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359: 843-848
27. Berkman RA, Merill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU, Otdfield EH. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993, 91:153-159
28. Morii K, Tanaka R, Washiyama K, Kumanishi T. Kuwano R: Expression of vascular endothelial growth factor in capillary hemangioblastoma Biochem Biophys Res Commun 1993, 194.749-755
29. Wizigmann-Voos S, Breier G, Risau W, Plate KH Upregulation of vascular endotheliai growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas Cancer Res 1995, 55 1358-1364
30. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukarnoto T, Kumamoto Y, Sugimura T Terada M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 1994, 54 4233-4237
31. Weindel K, Moringlane JR, Marmé D, Weich HA. Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumour tissue and cyst fluid, the key to angiogenesis? Neurosurgery 1994, 35:439-449
32. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Fusco A, Persico MG: Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 1995 (in press)
33. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M: Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (fit) closely related to the frns family. Oncogene 1990, 5:519-524
34. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoetic cells and exhibiting close genetic link-age to c-Wi Proc Natl Acad Sci USA 1991, 88 9026-9030
35. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255: 989-991
36. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991, 6 1677-1683
37. Terman BI, Dougher-Vermazen M, Dimitrov D, Armellino DC, Gospodarowicz D, Böhlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 1992, 187:1579-1586
38. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor J Biol Chem 1994, 269.25646-25654
39. Aprelikova O, Pajusola K, Partanen J, Armstrong E, Alitalo R, Bailey SK, McMahon J, Wasmuth J, Huebner K, Alitalo K FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter Cancer Res 1992, 52 746-748
40. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines Cancer Res 1992, 52.5738-5742
41. Galland F, Karamysheva A, Pebusque MJ, Borg JP, Rottapel R, Dubreuil P, Rosnet O, Birnbaum D: The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor Oncogene 1993, 8.1233-1240
42. Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K The related FLT4, FLT1 and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells J Exp Med 1993, 178 2077-2088
43. Partanen J, Armstrong E, Mäkelä TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K: A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains Mol Cell Biol 1992, 12 1698-1707
44. Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K. Enhanced expression of the Tie receptor tyrosine kinase in endothelial cells during neovascularisation Blood 1992, 80 2548-2555
45. Korhonen J, Polvi A, Partanen J, Alitalo K: The mouse Tie receptor tyrosine kinase gene: expression during embryonic angiogenesis Oncogene 1993, 8 395-403
46. Martin P, Papayannopuolou TH: HEL cells: a new human erythroleukaemia cell line with spontaneous and induced globin expression Science 1982, 216:1233-1235
47. Wilkinson DG, Bailes JA, McMahon AP: Expression of the proto-oncogene inf-1 is restricted to specific neural cells in the developing mouse embryo Cell 1987, 50. 79-88
48. Wilkinson DG, Bailes JA, Champion JE, McMahon AP A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression Development (Camb) 1987, 99.493-500
49. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of von Willebrand factor by cultured human endothelial cells Proc Natl Acad Sci USA 1974, 71:1906-1909
50. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasms. Am J Clin Pathol 1991, 96 25-31
51. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995, 146:1029-1039
52. Kim KJ, Bing L, Winer J, Armanini M, Gillett N, Philips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis supresses tumour growth in vivo. Nature 1993, 362.841-846
53. Akutsu Y, Aida T, Nakazawa S, Asano G Localization of acidic and basic fibroblast growth factor mRNA in human brain tumors Jpn J Cancer Res 1991, 82 1022-1027
54. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumours. Mol Biol Cell 1992, 3 211-220
55. Maher ER, Yates JRW, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith M: Clinical features and natural history of von Hippel-Lindau disease. J Med 1990, 77 1151-1163
56. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt I, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DSR, Dean M, Gtavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D. Chumakov I, Cohen D, Chinault AG, Maher ER, Linehan WM, Zbar B, Lerman MI. Identification of the von Hippel-Lindau disease tumor supressor gene. Science 1993, 260 1317-1320
57. Duan DR, Pause A, Burgess WH, Aso T, Chen DYT Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD: Inhibition of transcription elongation by the VHL tumor suppressor protein Science 1995, 269 1402-1406
58. Kibel A, Iliopoulos O, DeCapno JA, Kaelin WG Jr: Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C. Science 1995, 269 1444-1446
59. Bohling T, Haltia M, Rosenlöf K. Fyhrqvist F Erythropoietin in capillary hemangioblastomas Acta Neuropathol (Berl) 1987, 74.324-328
60. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi B-Z: Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994, 5:89-97
61. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992, 267 6093-6098
62. Soker S, Goldstaub D, Svanhn CM, Vlodavsky I, Levi B-Z, Neufeld G. Variations in size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors Biochem Biophys Res Commun 1994, 203:1339-1347
63. Rupp E, Siegbahn A, Ronnstrand L, Wernstedt C, Claesson-Welsh L, Heldin CH: A unique autophospnorylation site in the platelet-derived growth factor-α receptor from a heterodimeric receptor complex Eur J Biochem 1994, 225:29-41
64. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh V, Fang GH, Dumont D, Breitman M, Alitalo K: Expression of the FLT4 receptor tyrosine kinase becomes restricted to endothelium of lymphatic vessels and some high endoihelial venules during development. Proc Natl Acad Sci USA 1995, 92:3566-3570
65. Ho K. Ultrastructure of cerebellar capillary hemangioblastoma I Weibel-Palade bodies and stromal cell histogenesis J Neuropathol Exp Neurol 1984, 43:592-608
66. Seyama S, Ohta M, Nishio S, Matsushima T Cells constituting cerebellar hemangioblastomas: ultrastructural study Acta Pathol Jpn 1982, 32.399-413
67. Kamitani K, Masuzawa H, Sato J, Kanazawa I: Capillary hemangioblastoma: histogenesis of stromal cells Acta Neuropathol (Berl) 1987, 73.370-378
68. Kepes JJ, Rengachary SS, Lee SH. Astrocytes in hemangioblastomas of the central nervous system and their relationship to stromal cells Acta Neuropathol (Berl) 1979, 47:99-104
69. Deck JHN, Rubinstein LJ Glial fibrillary acidic protein in stromal cells of some capillary hemangioblastomas: significance and possible implications of an immunoperoxidase study. Acta Neuropathol (Berl) 1981, 54: 173-181
70. Tanimura A, Nakamura Y, Hachisuka H, Tanimura YA. Hemangioblastoma of the central nervous system: nature of the stromal cells as studied by the immunoperoxidase technique. Hum Pathol 1984, 15:866-869
71. Ironside JW, Stephenson TJ, Royds JA, Mills PM, Taylor CB, Rider CC, Timperley WR: Stromal cells in cerebellar hemangioblastomas. an immunohistochemical study. Histopathology 1988, 12:29-40
72. Böhling T, Paetau A, Ekblom P, Haltia M: Distribution of endothelial and basement membrane markers in angiogenic tumours of the nervous system. Acta Neuropathol (Berl) 1983. 62.67-72
73. Jurco S, Nadji M, Harvey DG, Parker JC, Font RL, Morales AR: Hemangioblastomas: histogenesis of the stromal cell studied by immunohistochemistry. Hum Pathol 1982, 13:13-18
74. Miettinen M, Lindenmayer AE Chaubal A: Endothelial cell markers CD31, CD34 and BNH9 antibody to H-and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumours and comparison with von Willebrand factor Mod Pathol 1994, 7:82-90
75. Nemez Z, Fibrohistiocytic differentiation in capillary hemangioblastoma. Hum Pathol 1992, 23 805-810
76. Nemez Z. Differentiation markers in hemangiopericytoma Cancer 1992, 69.133-140
77. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U. Vascular endothelial growth factor B (VEGF B), a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996 (in press)
78. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the FHU (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996 (in press)